CL

Costas Lyssiotis

SR Scripps Research: 5 patents #168 of 1,293Top 15%
BC Beth Israel Deaconess Medical Center: 3 patents #96 of 672Top 15%
DI Dana-Farber Cancer Institute: 3 patents #302 of 1,343Top 25%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
CU Cornell University: 1 patents #786 of 1,984Top 40%
IR Irm: 1 patents #133 of 277Top 50%
📍 Boston, MA: #962 of 5,993 inventorsTop 20%
🗺 Massachusetts: #15,851 of 88,656 inventorsTop 20%
Overall (All Time): #624,197 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11246873 Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate Peter G. Schultz, Luke Lairson, Vishal Deshmukh 2022-02-15
10837015 Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer Alec C. Kimmelman, Jaekyoung Son, Lewis C. Cantley 2020-11-17
10660899 Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate Peter G. Schultz, Luke Lairson, Vishal Deshmukh 2020-05-26
10494365 Small molecule inhibitor of 3-phosphoglycerate dehydrogenase and uses thereof Lewis C. Cantley, Edouard Mullarky, Luke Lairson, Natasha Lucki 2019-12-03
10493080 Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate Peter G. Schultz, Luke Lairson, Vishal Deshmukh 2019-12-03
10138479 Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer Alec C. Kimmelman, Jaekyoung Son, Lewis C. Cantley 2018-11-27
9745631 Methods for diagnosing and treating oncogenic kras-associated cancer Ronald A. DePinho, Lewis C. Cantley, Alec C. Kimmelman, Haoqiang Ying 2017-08-29
9592288 Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate Peter G. Schultz, Luke Lairson, Vishal Deshmukh 2017-03-14